Brodeur GM - Search Results

1

High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.

Tang XX, Evans AE, Zhao H, Cnaan A, London W, Cohn SL, Brodeur GM, Ikegaki N. Tang XX, et al. Among authors: brodeur gm. Clin Cancer Res. 1999 Jun;5(6):1491-6. Clin Cancer Res. 1999. PMID: 10389937

2

Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.

Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM. Nakagawara A, et al. Among authors: brodeur gm. Cancer Res. 1992 Mar 1;52(5):1364-8. Cancer Res. 1992. PMID: 1737399

3

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Look AT, et al. Among authors: brodeur gm. J Clin Oncol. 1991 Apr;9(4):581-91. doi: 10.1200/JCO.1991.9.4.581. J Clin Oncol. 1991. PMID: 2066755 Clinical Trial.

4

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM. Cohn SL, et al. Among authors: brodeur gm. Oncogene. 1990 Dec;5(12):1821-7. Oncogene. 1990. PMID: 2284101

5

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, et al. Brodeur GM, et al. J Clin Oncol. 1988 Dec;6(12):1874-81. doi: 10.1200/JCO.1988.6.12.1874. J Clin Oncol. 1988. PMID: 3199170

6

International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.

Brodeur GM, Seeger RC, Barrett A, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G, et al. Brodeur GM, et al. Prog Clin Biol Res. 1988;271:509-24. Prog Clin Biol Res. 1988. PMID: 3406015 No abstract available.

7

Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM. Maris JM, et al. Among authors: brodeur gm. Cancer Res. 1995 Oct 15;55(20):4664-9. Cancer Res. 1995. PMID: 7553646

8

Molecular basis for heterogeneity in human neuroblastomas.

Brodeur GM. Brodeur GM. Eur J Cancer. 1995;31A(4):505-10. doi: 10.1016/0959-8049(95)00040-p. Eur J Cancer. 1995. PMID: 7576954 Review.

9

Differential expression of pleiotrophin and midkine in advanced neuroblastomas.

Nakagawara A, Milbrandt J, Muramatsu T, Deuel TF, Zhao H, Cnaan A, Brodeur GM. Nakagawara A, et al. Among authors: brodeur gm. Cancer Res. 1995 Apr 15;55(8):1792-7. Cancer Res. 1995. PMID: 7712489

10

No CDKN2 mutations in neuroblastomas.

Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur GM. Beltinger CP, et al. Among authors: brodeur gm. Cancer Res. 1995 May 15;55(10):2053-5. Cancer Res. 1995. PMID: 7743501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters